10 Big Names Crushing the Market

Page 9 of 9

1. Adaptive Biotechnologies Corporation (NASDAQ:ADPT)

Adaptive Biotechnologies soared to a new three-year high on Friday, as investors resorted to bargain-hunting after the stock fell back to the $13 level earlier in the week.

At intra-day trading, the stock climbed to its highest price of $18.98 before trimming a few cents to end the day just up by 14.03 percent at $18.61 apiece.

Additionally, investors loaded portfolios following the recently concluded Jefferies London Healthcare Conference 2025, where it announced its operational updates and outlook for the full year.

Among others, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) said it expects its pharmaceutical services to generate $20 million in revenues, and anticipates EMR integrated testing volumes to exceed 50 percent by year-end.

Meanwhile, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is also set to participate in the upcoming Piper Sandler Healthcare Conference on December 3.

In the third quarter of the year, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) swung to an attributable net income of $9.5 million from a $32.07 million net loss in the same period last year.

Revenues expanded by 102 percent to $93.97 million from $46.4 million year-on-year, including $33.7 million of revenues from Immune Medicine recognized upon the full amortization of payments previously received under the Genentech Agreement, which was terminated in August 2025.

While we acknowledge the potential of ADPT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ADPT and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.

Page 9 of 9